Compare GBIO & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GBIO | TWIN |
|---|---|---|
| Founded | 2016 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 224.5M |
| IPO Year | 2020 | N/A |
| Metric | GBIO | TWIN |
|---|---|---|
| Price | $5.77 | $16.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $8.88 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 65.1K | 28.7K |
| Earning Date | 11-05-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $15,270,000.00 | ★ $347,837,000.00 |
| Revenue This Year | N/A | $10.79 |
| Revenue Next Year | N/A | $8.43 |
| P/E Ratio | ★ N/A | $683.53 |
| Revenue Growth | N/A | ★ 14.24 |
| 52 Week Low | $3.00 | $6.16 |
| 52 Week High | $12.40 | $17.30 |
| Indicator | GBIO | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 60.89 | 55.50 |
| Support Level | $5.40 | $15.06 |
| Resistance Level | $5.69 | $18.00 |
| Average True Range (ATR) | 0.22 | 0.56 |
| MACD | 0.04 | 0.09 |
| Stochastic Oscillator | 87.72 | 53.40 |
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.